Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd
As of 17 November 2026, for the company name Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd as recorded, 5 applications with this name as first applicant are listed as under review at China's CDE; the CDE acceptance records name it as first applicant on 24 records, across 20 drug names; since 21 August 2026, the records list Marketing application approved: 2 applications, Accepted: 2 applications, No longer listed under review: 1 application; the chemical-drug catalogue lists 13 active records with this name as holder; 14 active API registrations list this name as first registered company; 3 further acceptance records name it after the first applicant.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/17.
Drug filings
24 acceptance records as first applicant, grouped into 20 source drug names. Source data as of 2026/11/17.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
醋酸地非法林注射液 · No verified English name 1 records · Latest accepted 2026/10/22
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2602593 | Generic | 2026/10/22 | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | CDE ↗ |
Edaravone and Dexborneol Concentrated Solution for Injection 1 records · Latest accepted 2026/09/28
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2602418 | Generic | 2026/09/28 | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | CDE ↗ |
Landiolol Hydrochloride for Injection 1 records · Latest accepted 2026/08/18
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2602046 | Generic | 2026/08/18 | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | CDE ↗ |
注射用磷酸左奥硝唑酯二钠 · No verified English name 1 records · Latest accepted 2026/08/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601953 | Generic | 2026/08/10 | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | CDE ↗ |
注射用甲苯磺酸奥马环素 · No verified English name 1 records · Latest accepted 2025/06/21
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502238 | Generic | 2025/06/21 | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | CDE ↗ |
Mupirocin Ointment 2 records · Latest accepted 2025/05/11
Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501705 | Generic | 2025/05/11 | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd; Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHS2404251 | Generic | 2024/12/07 | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd; Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Cetrorelix Acetate for Injection 1 records · Latest accepted 2025/03/15
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501083 | Generic | 2025/03/15 | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | CDE ↗ |
Oxytocin Injection 1 records · Latest accepted 2025/01/28
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500550 | Generic | 2025/01/28 | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | CDE ↗ |
Crisaborole Ointment 1 records · Latest accepted 2024/12/03
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2404142 | Generic | 2024/12/03 | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd; Nanjing Hai Na Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Adapalene Gel 1 records · Latest accepted 2024/11/23
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2404021 | Generic | 2024/11/23 | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd; Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Potassium Phosphates Injection 1 records · Latest accepted 2024/03/16
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450199 | Supplement | 2024/03/16 | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd; Yang Zhou Zhong Bao Pharma Co., Ltd. romanized | CDE ↗ |
Linaclotide Capsules 1 records · Latest accepted 2023/09/20
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302540 | Generic | 2023/09/20 | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd; Jiangsu Fei Ma Pharma Co., Ltd. romanized | CDE ↗ |
Carbetocin Injection 2 records · Latest accepted 2023/09/05
Supplement · 2
二甲双胍恩格列净片(I) · No verified English name 1 records · Latest accepted 2023/08/30
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302317 | Generic | 2023/08/30 | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd; Jiangsu Fei Ma Pharma Co., Ltd. romanized | CDE ↗ |
二甲双胍恩格列净片(V) · No verified English name 1 records · Latest accepted 2023/08/30
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302318 | Generic | 2023/08/30 | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd; Jiangsu Fei Ma Pharma Co., Ltd. romanized | CDE ↗ |
注射用BGC0222 · No verified English name 1 records · Latest accepted 2023/04/07
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2300083 | Supplement | 2023/04/07 | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | CDE ↗ |
Lornoxicam for Injection 1 records · Latest accepted 2022/08/05
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250478 | Supplement | 2022/08/05 | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | CDE ↗ |
Terlipressin for Injection 1 records · Latest accepted 2022/08/04
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250477 | Supplement | 2022/08/04 | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | CDE ↗ |
Sitagliptin Phosphate Tablets 3 records · Latest accepted 2022/04/11
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200560 | Generic | 2022/04/11 | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd; Jiangsu Fei Ma Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2200559 | Generic | 2022/04/11 | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd; Jiangsu Fei Ma Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2200558 | Generic | 2022/04/11 | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd; Jiangsu Fei Ma Pharma Co., Ltd. romanized | CDE ↗ |
Thymalfasin for Injection 1 records · Latest accepted 2021/01/01
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2050816 | Supplement | 2021/01/01 | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | CDE ↗ |
Changes in the last 90 days
5 events from 2026/08/21 to 2026/11/18. CDE data as of 2026/11/17; NMPA data as of 2026/11/17.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Marketing application approved: 2 applicationsAccepted: 2 applicationsNo longer listed under review: 1 application
- 2026/11/10Marketing application approved
Mupirocin Ointment
CYHS2501705 · 国药准字H20266580
Fact date: 2026/11/10 · Publication date: 2026/11/13 · Date added to this site: 2026/11/14
View source · Table row 69 ↗ - 2026/11/03Marketing application approved
Oxytocin Injection
CYHS2500550 · 国药准字H20266441
Fact date: 2026/11/03 · Publication date: 2026/11/05 · Date added to this site: 2026/11/06
View source · Table row 27 ↗ - 2026/10/29No longer listed under review
Mupirocin Ointment
CYHS2501705
Fact date: 2026/10/29 · Date added to this site: 2026/10/29
Accepted: 2025/05/11
no longer on the CDE under-review list as of the data cut-off; NMPA published approval-document delivery for this acceptance number on 2026/11/13 (approval no.: 国药准字H20266580; approval date: 2026/11/10) · NMPA source · row 69
NMPA · Table row 69 ↗ View source ↗ - 2026/10/22Accepted
醋酸地非法林注射液 · No verified English name
CYHS2602593
Fact date: 2026/10/22 · Date added to this site: 2026/10/22
View source ↗ - 2026/09/28Accepted
Edaravone and Dexborneol Concentrated Solution for Injection
CYHS2602418
Fact date: 2026/09/28 · Date added to this site: 2026/10/21
View source ↗
Under review
5 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/17.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| 醋酸地非法林注射液 · No verified English name | CYHS2602593 | Generic | 2026/10/22 | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | CDE ↗ |
| Edaravone and Dexborneol Concentrated Solution for Injection | CYHS2602418 | Generic | 2026/09/28 | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | CDE ↗ |
| Landiolol Hydrochloride for Injection | CYHS2602046 | Generic | 2026/08/18 | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | CDE ↗ |
| 注射用磷酸左奥硝唑酯二钠 · No verified English name | CYHS2601953 | Generic | 2026/08/10 | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | CDE ↗ |
| Linaclotide Capsules | CYHS2302540 | Generic | 2023/09/20 | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd; Jiangsu Fei Ma Pharma Co., Ltd. romanized | CDE ↗ |
Catalogue holder records
13 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/17. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Cetrorelix Acetate for Injection | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | 国药准字H20265766 | 2026/08/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Potassium Phosphates Injection | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | Yang Zhou Zhong Bao Pharma Co., Ltd. romanized | 国药准字H20258097 | 2025/06/03 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 二甲双胍恩格列净片(V) · No verified English name | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | Jiangsu Fei Ma Pharma Co., Ltd. romanized | 国药准字H20249363 | 2024/11/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 二甲双胍恩格列净片(I) · No verified English name | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | Jiangsu Fei Ma Pharma Co., Ltd. romanized | 国药准字H20249362 | 2024/11/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sitagliptin Phosphate Tablets | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | Jiangsu Fei Ma Pharma Co., Ltd. romanized | 国药准字H20243974 | 2024/06/11 | Not stated by source | CDE ↗ |
| Sitagliptin Phosphate Tablets | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | Jiangsu Fei Ma Pharma Co., Ltd. romanized | 国药准字H20243975 | 2024/06/11 | Not stated by source | CDE ↗ |
| Sitagliptin Phosphate Tablets | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | Jiangsu Fei Ma Pharma Co., Ltd. romanized | 国药准字H20243973 | 2024/06/11 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lornoxicam for Injection | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | 国药准字H20113080 | 2023/10/24 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Terlipressin for Injection | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | 国药准字H20203202 | 2023/09/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Carbetocin Injection | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | 国药准字H20193373 | 2023/07/17 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Thymalfasin for Injection | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | 国药准字H20103201 | 2022/01/13 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Octreotide Acetate Injection | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | 国药准字H20133091 | 2021/11/09 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Octreotide Acetate Injection | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | 国药准字H20133092 | 2021/11/09 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
14 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/17.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 醋酸地非法林 · No verified English name | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | Y20260000643 | I | 2026/09/01 | CDE ↗ |
| 醋酸兰瑞肽 · No verified English name | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | Y20240000866 | A | 2026/04/27 | CDE ↗ |
| 醋酸地加瑞克 · No verified English name | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | Y20240000771 | I | 2025/05/20 | CDE ↗ |
| 醋酸地非法林 · No verified English name | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | Y20240000239 | I | 2024/04/02 | CDE ↗ |
| 利那洛肽 · No verified English name | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | Y20230000696 | A | 2025/09/09 | CDE ↗ |
| 醋酸西曲瑞克 · No verified English name | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | Y20230000378 | A | 2024/12/07 | CDE ↗ |
| 司美格鲁肽 · No verified English name | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | Y20220001169 | I | 2023/01/09 | CDE ↗ |
| 利拉鲁肽 · No verified English name | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | Y20220000141 | I | 2022/09/13 | CDE ↗ |
| 缩宫素 · No verified English name | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | Y20210000758 | A | 2025/06/13 | CDE ↗ |
| 胸腺法新 · No verified English name | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | Y20190009471 | A | — | CDE ↗ |
| 胸腺五肽 · No verified English name | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | Y20190003367 | A | 2025/05/07 | CDE ↗ |
| 卡贝缩宫素 · No verified English name | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | Y20170000889 | A | 2024/01/25 | CDE ↗ |
| 醋酸去氨加压素 · No verified English name | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | Y20170000345 | A | 2024/03/15 | CDE ↗ |
| 醋酸曲普瑞林 · No verified English name | Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | Y20170000344 | A | 2023/05/14 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
3 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/17.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Sugammadex Sodium Injection | CYHS2201201 | Generic | 2022/08/01 | Shanghai Hui Lun Jiangsu Pharma Co., Ltd. romanized; Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | CDE ↗ |
| Sugammadex Sodium Injection | CYHS2201200 | Generic | 2022/08/01 | Shanghai Hui Lun Jiangsu Pharma Co., Ltd. romanized; Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | CDE ↗ |
| Nicorandil for Injection | CYHS2201022 | Generic | 2022/07/06 | Suzhou Te Rui Pharma Co., Ltd. romanized; Suzhou Tianma Pharmaceutical Group Tianji biopharmaceutical Co., Ltd | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/17
- Chemical-drug catalogue
- Last successful update: 2026/11/17
- API registrations
- Last successful update: 2026/11/17
- NMPA drug delivery notices
- Last successful update: 2026/11/17
Loaded notices dated 2026-11-03 to 2026-11-17; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.